Barclays PLC Neogenomics Inc Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Neogenomics Inc stock. As of the latest transaction made, Barclays PLC holds 230,901 shares of NEO stock, worth $3.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

230,901

Previous 230,901 -0.0%

Holding current value

$3.78 Million

Previous $3.41 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$13.4 - $17.73 $2.28 Million - $3.02 Million	170,218 Added 280.5%	230,901 $3.41 Million
Q2 2024 Aug 14, 2024	SELL	$13.01 - $15.77 $908,826 - $1.1 Million	-69,856 Reduced 53.51%	60,683 $842,000
Q1 2024 May 15, 2024	SELL	$14.06 - $16.79 $1.11 Million - $1.32 Million	-78,788 Reduced 37.64%	130,539 $2.05 Million
Q4 2023 Feb 15, 2024	BUY	$11.67 - $20.73 $1.63 Million - $2.89 Million	139,461 Added 199.61%	209,327 $3.39 Million
Q3 2023 Nov 07, 2023	SELL	$12.15 - $17.85 $43,047 - $63,242	-3,543 Reduced 4.83%	69,866 $859,000
Q2 2023 Aug 03, 2023	BUY	$14.1 - $19.83 $113,970 - $160,285	8,083 Added 12.37%	73,409 $1.18 Million
Q1 2023 May 04, 2023	SELL	$9.09 - $19.45 $241,030 - $515,736	-26,516 Reduced 28.87%	65,326 $1.14 Million
Q4 2022 Feb 13, 2023	BUY	$6.45 - $12.07 $322,183 - $602,908	49,951 Added 119.24%	91,842 $848,000
Q3 2022 Nov 03, 2022	SELL	$7.86 - $12.91 $12.5 Million - $20.6 Million	-1,596,434 Reduced 97.44%	41,891 $361,000
Q2 2022 Aug 12, 2022	BUY	$7.06 - $13.97 $10.8 Million - $21.4 Million	1,532,113 Added 1442.5%	1,638,325 $13.4 Million
Q1 2022 May 16, 2022	SELL	$12.15 - $35.28 $610,999 - $1.77 Million	-50,288 Reduced 32.13%	106,212 $1.29 Million
Q4 2021 Feb 14, 2022	BUY	$30.49 - $48.49 $566,717 - $901,283	18,587 Added 13.48%	156,500 $5.34 Million
Q3 2021 Nov 09, 2021	BUY	$41.66 - $52.52 $570,367 - $719,051	13,691 Added 11.02%	137,913 $6.65 Million
Q2 2021 Aug 13, 2021	SELL	$36.62 - $51.69 $1.15 Million - $1.62 Million	-31,408 Reduced 20.18%	124,222 $5.61 Million
Q1 2021 May 13, 2021	BUY	$41.56 - $59.88 $832,114 - $1.2 Million	20,022 Added 14.76%	155,630 $7.51 Million
Q4 2020 Feb 11, 2021	SELL	$36.08 - $56.47 $253,137 - $396,193	-7,016 Reduced 4.92%	135,608 $7.3 Million
Q3 2020 Nov 12, 2020	BUY	$33.26 - $40.48 $924,561 - $1.13 Million	27,798 Added 24.21%	142,624 $5.26 Million
Q2 2020 Aug 12, 2020	BUY	$24.21 - $31.02 $322,937 - $413,775	13,339 Added 13.14%	114,826 $3.56 Million
Q1 2020 May 13, 2020	SELL	$20.5 - $34.53 $940,847 - $1.58 Million	-45,895 Reduced 31.14%	101,487 $2.8 Million
Q4 2019 Feb 10, 2020	BUY	$18.96 - $29.84 $228,335 - $359,363	12,043 Added 8.9%	147,382 $4.31 Million
Q3 2019 Nov 14, 2019	BUY	$19.12 - $26.24 $540,426 - $741,673	28,265 Added 26.4%	135,339 $2.59 Million
Q2 2019 Aug 14, 2019	BUY	$19.57 - $24.1 $832,057 - $1.02 Million	42,517 Added 65.86%	107,074 $2.35 Million
Q1 2019 May 15, 2019	SELL	$12.14 - $20.46 $636,876 - $1.07 Million	-52,461 Reduced 44.83%	64,557 $1.32 Million
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $573,307 - $943,611	51,006 Added 77.27%	117,018 $1.48 Million
Q3 2018 Nov 14, 2018	BUY	$12.5 - $15.38 $17,362 - $21,362	1,389 Added 2.15%	66,012 $1.01 Million
Q2 2018 Aug 14, 2018	BUY	$7.99 - $14.05 $90,510 - $159,158	11,328 Added 21.26%	64,623 $846,000
Q1 2018 May 15, 2018	BUY	$7.23 - $8.76 $305,930 - $370,670	42,314 Added 385.34%	53,295 $435,000
Q4 2017 Feb 14, 2018	SELL	$8.02 - $11.18 $207,814 - $289,696	-25,912 Reduced 70.24%	10,981 $98,000
Q3 2017 Nov 14, 2017	BUY	$9.11 - $11.26 $336,095 - $415,415	36,893	36,893 $410,000

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.06B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account